Kodiak Sciences Inc
NASDAQ:KOD

Watchlist Manager
Kodiak Sciences Inc Logo
Kodiak Sciences Inc
NASDAQ:KOD
Watchlist
Price: 5.26 USD 3.14% Market Closed
Market Cap: 276.8m USD
Have any thoughts about
Kodiak Sciences Inc?
Write Note

P/S
Price to Sales

0
Current
0
Median
7.7
Industry
Higher than median
Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
0
=
Market Cap
276.8m USD
/
Revenue
0 USD
All Countries
Close
Revenue Growth P/S to Growth
US
Kodiak Sciences Inc
NASDAQ:KOD
Average P/S: 3 781 935.4
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
37 817 419.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.1
6%
1
US
Amgen Inc
NASDAQ:AMGN
4.7
3%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
4.5
2%
2.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.7
9%
1.2
US
E
Epizyme Inc
F:EPE
1 862.9
N/A N/A
AU
CSL Ltd
ASX:CSL
5.3
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.2
8%
0.6
US
S
Seagen Inc
F:SGT
17.9
30%
0.6
NL
argenx SE
XBRU:ARGX
17.4
55%
0.3

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
N/A
2-Years Forward
P/S
N/A
3-Years Forward
P/S
N/A